Impact of Injectable Progestogen Contraception in Early Puerperium on Lactation and Infant Health
Introduction: Unmet need for family planning approaches 40% or higher and many women are at risk of unintended pregnancy. Progesterone contraception after birth is frequently recommended, but concern remain of inhibition of lactation or effects on infant health. In present study we aimed to eval...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2014-03-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/4110/23-%207775_290114_R1_7775_CE[Ra]_PF1(PAK)_PFA(AK).pdf |
Summary: | Introduction: Unmet need for family planning approaches 40%
or higher and many women are at risk of unintended pregnancy.
Progesterone contraception after birth is frequently recommended,
but concern remain of inhibition of lactation or effects on infant
health. In present study we aimed to evaluate impact of short
term use of injectable depot medroxy progesterone acetate
(DMPA) if given in early post partum period on infant health and
breast feeding performance.
Material and Methods: A prospective case control study was
conducted and 250 women immediately after delivery were
recruited in the study. 150 women who were recruited as study
group received Inj. DMPA 150 mg intra muscularly after initiation
of lactation before discharge from hospital (Day 2-Day 10 of
their delivery). 100 post partum women, not using hormonal
contraception were taken as controls. All the subjects were
followed to complete a full 6 months follow up. Duration and
frequency of lactation, gain in weight, gain in height and any
illness spells in the infant were noted at 6 weeks, 3 months and
6 months follow up. In the study group 100 subjects completed
6 months follow-up. The statistical analysis was carried out by
using SPSS software version 7. The statistical technique used
was z score(significance shown by z score> 1.96) and repeated
measure analysis (two way Anova technique).
Results: Hundred percent of primigravidas in the study group
and 95% in the control group were satisfied with their lactation
amount. The average gain in height was comparable in both
study and control group {4.36±0.56 vs 4.33±0.54 (z score 0.38)
at 6 weeks, 12.44±0.73 vs 12.40±0.71 (z score 0.39) at 3 months
17.30±0.91 vs 17.28±0.83 (z score 0.16) at 6 months}. Similarly
average gain in weight was also not significantly different in
two groups {0.89±0.11 vs 0.93±0.10 (z score 0.71) at 6 weeks,
1.77±0.17 vs 1.78±0.16 (z score 1.07) at 3 months and 3.53±0.30
vs 3.46±0.33 (z score 1.19) at 6 months}. The results were
comparable with other studies.
Conclusion: Injectable DMPA use as a contraceptive in the
immediate post partum period was found to be a safe and
effective alternate method with no deleterious effect on mother’s
milk and infant’s growth. |
---|---|
ISSN: | 2249-782X 0973-709X |